Riyaz Bashir, Malcolm Foster, Ayman Iskander, Amir Darki, Wissam Jaber, Parth M Rali, Vladimir Lakhter, Ripal Gandhi, Andrew Klein, Rohit Bhatheja, Charles Ross, Kannan Natarajan, Aravinda Nanjundappa, John F Angle, Kenneth Ouriel, Nancy E Amoroso, Brian G Firth, Anthony J Comerota, Gregory Piazza, Kenneth Rosenfield, Akhilesh K Sista
BACKGROUND: Catheter-directed thrombolysis (CDT) has been associated with rapid recovery of right ventricular (RV) function. The Bashir catheter was developed for enhanced thrombolysis in large vessels such as the pulmonary arteries (PAs) with lower doses of tissue plasminogen activator (tPA). OBJECTIVES: The aim of this study was to evaluate the efficacy and safety of tPA infused using a pharmacomechanical (PM) CDT device called the Bashir endovascular catheter in patients with intermediate-risk acute pulmonary embolism (PE)...
December 12, 2022: JACC. Cardiovascular Interventions